Frontera Therapeutics
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa (NCT06492850) | Frontera Therapeutics | 2024-04-01 |
| Gene Therapy for DME (NCT06492876) | Frontera Therapeutics | 2023-11-15 |
| Gene Therapy(FT-003) for Wet AMD (NCT06492863) | Frontera Therapeutics | 2023-08-15 |
| Gene Therapy for Diabetic Macular Edema (NCT05916391) | Frontera Therapeutics | 2023-05-19 |
| Gene Therapy for Wet AMD (NCT05611424) | Frontera Therapeutics | 2023-05-01 |
| Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa (NCT05874310) | Frontera Therapeutics | 2023-02-01 |
| Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy (NCT05858983) | Frontera Therapeutics | 2022-11-30 |
Track Frontera Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.